ArticleCase reports in ophthalmological medicine2026
A Case of Juxtafoveal Microaneurysm in a Setting of PAMM: Diagnostic and Therapeutic Challenges.
Article in Case reports in ophthalmological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case of Juxtafoveal Microaneurysm in a Setting of PAMM: Diagnostic and Therapeutic Challenges.Case reports in ophthalmological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We are aimed at reporting a rare case of juxtafoveal microaneurysm in a young adult in the setting of paracentral acute middle maculopathy (PAMM) and discussing potential underlying mechanisms and therapeutic considerations. Methods: This study describes a single case report and a treatment trial with nitroglycerin. Results: We present a case of a 38-year-old male with recurrent migraines and juxtafoveal microaneurysm who was empirically treated with 0.4-mg nitroglycerin, resulting in subjective visual improvement and resolution of the lesion on SD-OCT. Conclusions: This report highlights the potential role of nitroglycerin as a therapeutic option for recurrent PAMM, emphasizing the need for further investigation into its efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.